The Effects of Chicken Extract on Mental Energy in Healthy Adults and the Underlying Mechanisms
NCT ID: NCT06021223
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
189 participants
INTERVENTIONAL
2023-08-22
2025-01-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A sub-study investigates the immediate biochemical changes after taking chicken extract.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Dietary Supplement Liquid Shot Products on Mental Energy, Cognition (Acuity),and Mood
NCT06384586
The Effect of Adaptogen Elixir on Sleep Improvement
NCT06279312
Effects of a Vitality Dietary Supplement on Physical and Mental Function in Middle-aged Adults
NCT01155076
The Effect of Avnace eZZe on Sleep Improvement
NCT07172607
Evaluation of Astaxanthin Properties on Anti-fatigue
NCT06593535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chicken extract supplement (high-dose)
140ml of chicken extract supplement (high-dose) to be consumed daily for 2 weeks
Chicken extract supplement (high-dose)
140ml of chicken extract supplement (high-dose) to be consumed daily for 2 weeks
Chicken extract supplement (low-dose)
140ml of chicken extract supplement (low-dose) to be consumed daily for 2 weeks
Chicken extract supplement (low-dose)
140ml of chicken extract supplement (low-dose) to be consumed daily for 2 weeks
Placebo
140ml of placebo (caesinate) to be consumed daily for 2 weeks
Placebo
140ml of placebo to be consumed daily for 2 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chicken extract supplement (high-dose)
140ml of chicken extract supplement (high-dose) to be consumed daily for 2 weeks
Chicken extract supplement (low-dose)
140ml of chicken extract supplement (low-dose) to be consumed daily for 2 weeks
Placebo
140ml of placebo to be consumed daily for 2 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Assessed by investigator to be in good health
* Normal cognition based on investigator's clinical judgement per the routine practice
* Modified PSQI score \> 5
* Agree to participate in the study and provide written informed consent
* Agree to abstain from herbal extracts or dietary supplements throughout the study period
Exclusion Criteria
* Concurrent pharmacological treatments
* Current systemic diseases or current/history of neurological or cerebrovascular diseases
* Active peptic ulcer, or a history of peptic ulcer within the last 2 years
* Medications or interventions in the last 4 weeks, which in the investigators' judgement could potentially affect the outcome measures
* Regular significant quantities of dietary supplements or herbal extracts (\> 2 times a week) in the last 4 weeks
* Regular excessive caffeine consumption, heavy alcohol consumption or heavy habitual smokers
* Any drastic changes in lifestyle (including diet, smoking, sleep, exercise, and mental and physical activities) in the last 4 weeks
* Not able to maintain the same lifestyle throughout the study period
* Inadequate visual and auditory acuity to allow neuropsychological testing per investigator's judgment
* Inability to undergo fMRI scan
* Any consumption of chicken extract supplement, or carnosine or anserine supplement, in the preceding 4 weeks
* History of allergy to caseinate, milk, or chicken meat
* Women who are pregnant or lactating or intending to do so
* Current enrolment in another interventional study
* Subjects who show unstable sleep habits during the previous month
* Excessive blood donation or blood drawn prior to baseline
35 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University Shuang Ho Hospital
OTHER
Brand's Suntory Asia
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University Hospital Shuang Ho Hospital
New Taipei City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BEC-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.